In Vivo Release of Vancomycin from Calcium Phosphate Cement

Abstract EN

Calcium phosphate cement (CPC) has good release efficiency and has therefore been used as a drug delivery system for postoperative infection.

The release profile of CPC has mainly been evaluated by in vitro studies, which are carried out by immersing test specimens in a relatively large amount of solvent.

However, it remains unclear whether antibiotic-impregnated CPC has sufficient clinical effects and release in vivo.

We examined the in vivo release profile of CPC impregnated with vancomycin (VCM) and compared this with that of polymethylmethacrylate (PMMA) cement.

To evaluate the release profile in vitro, the test specimens were immersed in 10 mL sterile phosphate-buffered saline per gram of test specimen and incubated at 37°C for 56 days in triplicate.

For in vivo experiments, the test specimens were implanted between the fascia and muscle of the femur of rats.

Residual VCM was extracted from the removed test specimens to determine the amount of VCM released into rat tissues.

CPC released more VCM over a longer duration than PMMA in vitro.

Released levels of VCM from CPC/VCM in vivo were 3.4-fold, 5.0-fold, and 8.6-fold greater on days 1, 7, and 28, respectively, than those released on the corresponding days from PMMA/VCM and were drastically greater on day 56 due to inefficient release from PMMA/VCM.

The amount of VCM released from CPC and PMMA was much higher than the minimum inhibitory concentration (1.56 μg) and lower than the detection limit, respectively.

Our findings suggest that CPC is a suitable material for releasing antibiotics for local action against established postoperative infection.